Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

PCRonline @ TCT Connect 2020

25 Sep 2020

View reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 online edition of TCT Connect. Check out the list here!

PCR @ TCT 2020

Long‐term safety of paclitaxel drug‐coated balloon‐only angioplasty for de novo coronary artery disease: the SPARTAN DCB study

16 Sep 2020

This study adds to the growing body of evidence demonstrating that DCB is a safe option for the treatment of de novo coronary lesions with NO signal towards increase in mortality up to 5-year follow-up.

Aditya Bharadwaj

Reviewer

Aditya Bharadwaj
Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Long‐term safety of paclitaxel drug‐coated balloon‐only angioplasty for de novo coronary artery disease

Revascularisation strategies - PCR e-Course 2020 Hot lines

29 Jul 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.

Revascularisation strategies

PCR e-Course Hot lines: drugs and devices for STEMI management

Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.

Hot line: drugs and devices for STEMI management

Evidence based PCI in patients at high bleeding risk – The LEADERS FREE trials

Watch this video to understand the importance of high bleeding risk, the safety and efficacy of polymer-free BA9-coated coronary stents and the impact of a new thin strut CoCr stent platform on clinical outcomes.

Speakers: Keith Oldroyd, Philip Urban, Franz Eberli

This interview supported by Biosensors Europe SA ...

Evidence-based PCI in patients at high bleeding risk

Randomised comparison of the polymer-free biolimus-coated BioFreedom stent with the ultrathin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with PCI: the SORT OUT IX Trial

03 Jul 2020

While investigations testing differences in efficacy and safety between drug-eluting stents according to the characteristics of the coating – durable, bioresorbable, or polymer-free – have shown mixed results, several studies have highlighted the benefit of implanting a device with thinner strut.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
The SORT OUT IX trial

The year in intervention: essential publications from EuroIntervention and the European Heart Journal

27 Jun 2020 – From PCR e-Course 2020

Watch this video to find out what were the most essential, impactful and influential papers published in EuroIntervention and the European Heart Journal over the past year, and learn more about the academic versus social impact of citations.

The year in intervention: essential publications from EuroIntervention and the European Heart Journal

Physiology or intracoronary imaging; or both? or none? - part 1

27 Jun 2020 – From PCR e-Course 2020

Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.

Physiology or intracoronary imaging; or both? or none?

Hot line on PCI: high bleeding risk and DAPT - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Hot lines on PCI: high bleeding risk and DAPT

Ultrathin-strut vs. thin-strut DES for primary PCI

27 Jun 2020 – From PCR e-Course 2020

Watch this session to review the role of ultrathin DES in optimising clinical outcomes for STEMI patients, to assess the impact of the BIOSTEMI trial to daily practice and to learn about real-world challenges when treating STEMI patients.

Videos included on this page: the Hot Line presentation...

Ultrathin-strut vs. thin-strut DES for primary PCI